Impact of reference point selection on DXA-based measurement of forearm bone mineral density
- 26 Downloads
Few studies have systematically evaluated the technical aspects of forearm bone mineral density (BMD) measurement. We found that BMD remained stable regardless of the reference point; however, the ROI identified was not always consistent. Our study highlights the importance of using the same reference point for serial measurements of forearm BMD.
Forearm fractures are clinically important outcomes from the perspective of morbidity, health care costs, and interruption of work. BMD of the forearm, as derived by dual-energy x-ray absorptiometry (DXA), is a better predictor of fracture at the forearm compared with BMD measured at other sites. However, very few studies have evaluated the technical aspects of selecting the ROI for forearm BMD measurement. This study aimed to compare the BMD values measured at the 1/3 radius site using three different reference points: the ulnar styloid process, the radial endplate, and the bifurcation of the ulna and radius.
Healthy Chinese patients participating in the control group of an ongoing study at Zhejiang Provincial People’s Hospital were recruited for this study. For each patient, a DXA scan (GE Lunar Prodigy) of the forearm was performed and BMD values were separately calculated using each of the three reference points to identify the ROI. Pearson correlation coefficients were calculated to examine the correlation between the BMD measures derived from each reference point. The F test and independent t test were applied for more robust analysis of the differences in the variances and means.
Sixty-eight healthy Chinese volunteers agreed to participate in this study. The root mean square standard deviation (RMS-SD) percentages of BMD values measured at the 1/3 radius site were 2.19%, 2.23%, and 2.20% when using the ulnar styloid process, radial endplate, and the bifurcation of the ulna and radius as the reference points, respectively. Pearson’s correlation coefficients for all pairwise comparisons among these three groups were greater than 0.99. F tests and independent t tests showed p values ranging from 0.92 to 0.99. However, we observed that among 10% of patients, choosing an ROI at the ulnar styloid process led to an inability to accurately determine the BMD at the ultra-distal radius.
Given equal ability to determine BMD at the 1/3 radius accurately, the radial endplate or the bifurcation of the ulna and radius should be preferentially selected as the reference point for routine forearm BMD measurements in order to avoid situations in which the ultra-distal radius BMD cannot be determined.
KeywordsForearm Dual-energy X-ray absorptiometry Bone mineral density Regions of interest Precision One-third radius
We would like to express our sincere gratitude to Professor Harry K. Genant for his scientific advice and suggestions. Dr. Hsieh is supported by NIH/Fogarty International Center K01TW009995.
Compliance with ethical standards
Conflicts of interest
- 1.WHO (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report Series 843 WHO, GenevaGoogle Scholar
- 6.Abrahamsen B, Jorgensen NR, Schwarz P (2015) Epidemiology of forearm fractures in adults in Denmark: national age- and gender-specific incidence rates, ratio of forearm to hip fractures, and extent of surgical fracture repair in inpatients and outpatients. Osteoporos Int 26(1):67–76. https://doi.org/10.1007/s00198-014-2831-1 CrossRefPubMedGoogle Scholar
- 8.Miller PD, Siris ES, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, Chen YT, Berger ML, Santora AC, Sherwood LM (2002) Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment. J Bone Miner Res 17(12):2222–2230CrossRefGoogle Scholar
- 12.Silverberg SJ, Gartenberg F, Jacobs TP, Shane E, Siris E, Staron RB, Bilezikian JP (1995) Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism. J Clin Endocrinol Metab 80(3):723–728. https://doi.org/10.1210/jcem.80.3.7883823 CrossRefPubMedGoogle Scholar
- 17.Urushibara N, Kato N, Adachi R, Nakamura Y, Mihara A, Uzawa T, Kitagawa S, Hayashi M, Kuroda T, Sone T (2014) Once-weekly teriparatide increases bone mineral density in the distal 1/10 radius, but not in the distal 1/3 radius. Springerplus 3:238. https://doi.org/10.1186/2193-1801-3-238 CrossRefPubMedPubMedCentralGoogle Scholar
- 18.Sugimoto T, Shiraki M, Fukunaga M, Hagino H, Sone T, Nakano T, Kishimoto H, Ito M, Yoshikawa H, Kishida M, Irie C, Nakamura T (2017) 24-month open-label teriparatide once-weekly efficacy research trial examining bone mineral density in subjects with primary osteoporosis and high fracture risk. Adv Ther 34(7):1727–1740. https://doi.org/10.1007/s12325-017-0568-x CrossRefPubMedPubMedCentralGoogle Scholar
- 19.Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344(19):1434–1441CrossRefGoogle Scholar
- 20.Michalska D, Luchavova M, Zikan V, Raska I Jr, Kubena AA, Stepan JJ (2012) Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis. Osteoporos Int 23(12):2885–2891. https://doi.org/10.1007/s00198-012-1955-4 CrossRefPubMedGoogle Scholar
- 21.Macdonald HM, Nishiyama KK, Hanley DA, Boyd SK (2011) Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis. Osteoporos Int 22(1):357–362. https://doi.org/10.1007/s00198-010-1226-1 CrossRefPubMedGoogle Scholar
- 22.Nakamura T, Sugimoto T, Nakano T, Kishimoto H, Ito M, Fukunaga M, Hagino H, Sone T, Yoshikawa H, Nishizawa Y, Fujita T, Shiraki M (2012) Randomized Teriparatide [human parathyroid hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk. J Clin Endocrinol Metab 97(9):3097–3106. https://doi.org/10.1210/jc.2011-3479 CrossRefPubMedGoogle Scholar
- 23.Zanchetta JR, Bogado CE, Ferretti JL, Wang O, Wilson MG, Sato M, Gaich GA, Dalsky GP, Myers SL (2003) Effects of teriparatide [recombinant human parathyroid hormone (1–34)] on cortical bone in postmenopausal women with osteoporosis. J Bone Miner Res 18(3):539–543. https://doi.org/10.1359/jbmr.2003.18.3.539 CrossRefPubMedGoogle Scholar
- 24.McClung MR, San Martin J, Miller PD, Civitelli R, Bandeira F, Omizo M, Donley DW, Dalsky GP, Eriksen EF (2005) Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med 165(15):1762–1768. https://doi.org/10.1001/archinte.165.15.1762 CrossRefPubMedGoogle Scholar
- 28.Engelke K, Libanati C, Liu Y, Wang H, Austin M, Fuerst T, Stampa B, Timm W, Genant HK (2009) Quantitative computed tomography (QCT) of the forearm using general purpose spiral whole-body CT scanners: accuracy, precision and comparison with dual-energy X-ray absorptiometry (DXA). Bone 45(1):110–118. https://doi.org/10.1016/j.bone.2009.03.669 CrossRefPubMedGoogle Scholar
- 30.Bonnick SL (2004) Bone densitiometry in clinical practice. Densitiometry techniques, 2nd edn. Humana Press, TotowaGoogle Scholar
- 35.Chang YJ, Yu W, Lin Q, Yao JP, Zhou XH, Tian JP (2012) Forearm bone mineral density measurement with different scanning positions: a study in right-handed Chinese using dual-energy X-ray absorptiometry. J Clin Densitom 15(1):67–71. https://doi.org/10.1016/j.jocd.2011.08.005 CrossRefPubMedGoogle Scholar